Gotsch Francesca, Romero Roberto, Chaiworapongsa Tinnakorn, Erez Offer, Vaisbuch Edi, Espinoza Jimmy, Kusanovic Juan Pedro, Mittal Pooja, Mazaki-Tovi Shali, Kim Chong Jai, Kim Jung Sun, Edwin Samuels, Nhan-Chang Chia-Ling, Hamill Neil, Friel Laraa, Than Nandor Gabor, Mazor Moshe, Yoon Bo Hyun, Hassan Sonia S
Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, Maryland, USA.
J Matern Fetal Neonatal Med. 2008 Sep;21(9):605-16. doi: 10.1080/14767050802212109.
Caspase-1 is a component of the NALP3 inflammasome, a cytosolic multiprotein complex that mediates the processing of pro-inflammatory caspases and cytokines. The inflammasome represents the first line of defense against cellular stress and is a crucial component of innate immunity. Caspase-1 is the enzyme responsible for the cleavage and activation of interleukin (IL)-1 beta, which is a potent pro-inflammatory cytokine, and plays a central role in the mechanisms leading to labor (preterm and term) particularly in the context of intrauterine infection/inflammation. In addition, caspase-1 cleaves IL-18 and IL-33. The objectives of this study were to determine whether there is a relationship between amniotic fluid concentrations of caspase-1 and gestational age, parturition (term and preterm), and intra-amniotic infection/inflammation (IAI).
A cross-sectional study was conducted including 143 pregnant women in the following groups: (1) mid-trimester of pregnancy (n = 18); (2) term not in labor (n = 25); (3) term in labor (n = 28); (4) preterm labor (PTL) who delivered at term (n = 23); (5) PTL without IAI who delivered preterm (n = 32); (6) PTL with IAI who delivered preterm neonates (n = 17). Caspase-1 concentrations in amniotic fluid were determined by a specific and sensitive immunoassay. Non-parametric statistics were used for analysis.
(1) Caspase-1 was detected in amniotic fluid of women at term, but in none of the mid-trimester samples. (2) Patients in labor at term had a significantly higher median amniotic fluid concentration of caspase-1 than women at term not in labor (term in labor: 10.5 pg/mL, range 0.0-666.0 vs. term not in labor: 5.99 pg/mL, range 0.0-237.4; p < 0.05). (3) Among patients with spontaneous PTL, those with IAI (median 41.4 pg/mL, range 0.0-515.0) had a significantly higher median amniotic fluid caspase-1 concentration than those without IAI who delivered preterm (median 0.0 pg/mL, range 0.0-78.4) and than those who delivered at term (median 0.0 pg/mL, range 0.0-199.5); p < 0.001 for both comparisons.
(1) The presence and concentration of caspase-1 in the amniotic fluid varies as a function of gestational age. (2) Women with spontaneous labor at term had a higher median caspase-1 amniotic fluid concentration than women at term without labor. This suggests that the inflammasome may be activated in spontaneous parturition at term. Since most women with labor do not have intra-amniotic infection, we propose that cellular stress during labor accounts for activation of the inflammasome. (3) Preterm labor associated with infection/inflammation was also associated with a high concentration of caspase-1, suggesting that infection may induce caspase-1 production and activation of the inflammasome. (4) The sequential activation of the inflammasome and caspase-1, leading to interleukin-1 beta processing and secretion, is a candidate pathway leading to the activation of the common pathway of parturition.
半胱天冬酶 -1是NALP3炎性小体的一个组成部分,NALP3炎性小体是一种胞质多蛋白复合物,介导促炎半胱天冬酶和细胞因子的加工处理。炎性小体是抵御细胞应激的第一道防线,是固有免疫的关键组成部分。半胱天冬酶 -1是负责切割和激活白细胞介素(IL)-1β的酶,IL-1β是一种强效促炎细胞因子,在导致分娩(早产和足月产)的机制中起核心作用,尤其是在宫内感染/炎症的情况下。此外,半胱天冬酶 -1还可切割IL-18和IL-33。本研究的目的是确定羊水半胱天冬酶 -1浓度与孕周、分娩(足月和早产)以及羊膜腔内感染/炎症(IAI)之间是否存在关联。
进行了一项横断面研究,纳入了143名孕妇,分为以下几组:(1)妊娠中期(n = 18);(2)足月未临产(n = 25);(3)足月临产(n = 28);(4)足月分娩的早产临产(PTL)(n = 23);(5)未发生IAI的早产临产且早产分娩者(n = 32);(6)发生IAI的早产临产且分娩早产新生儿者(n = 17)。采用特异性和敏感性免疫测定法测定羊水半胱天冬酶 -1浓度。采用非参数统计进行分析。
(1)足月孕妇的羊水中检测到了半胱天冬酶 -1,但妊娠中期样本中均未检测到。(2)足月临产患者羊水半胱天冬酶 -1的中位数浓度显著高于足月未临产的孕妇(足月临产:10.5 pg/mL,范围0.0 - 666.0 vs. 足月未临产:5.99 pg/mL,范围0.0 - 237.4;p < 0.05)。(3)在自发性PTL患者中,发生IAI的患者(中位数41.4 pg/mL,范围0.0 - 515.0)羊水半胱天冬酶 -1的中位数浓度显著高于未发生IAI的早产分娩患者(中位数0.0 pg/mL,范围0.0 - 78.4)以及足月分娩患者(中位数0.0 pg/mL,范围0.0 - 199.5);两组比较p均< 0.001。
(1)羊水中半胱天冬酶 -1的存在和浓度随孕周而变化。(2)足月自然临产的孕妇羊水半胱天冬酶 -1的中位数浓度高于足月未临产的孕妇。这表明足月自然分娩时炎性小体可能被激活。由于大多数临产孕妇没有羊膜腔内感染,我们推测分娩时的细胞应激导致了炎性小体的激活。(3)与感染/炎症相关的早产也与高浓度的半胱天冬酶 -1有关,这表明感染可能诱导半胱天冬酶 -1的产生并激活炎性小体。(4)炎性小体和半胱天冬酶 -1的相继激活,导致白细胞介素 -1β的加工处理和分泌,是导致分娩共同途径激活的一个候选途径。